Jennifer H. Lofland, Ph.D.

Affiliations: 
2004 Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Occupational Health and Safety, Health Care Management
Google:
"Jennifer Lofland"
Cross-listing: PHTree

Parents

Sign in to add mentor
Kevin D. Frick grad student 2004 Johns Hopkins
 (Access to health care and workplace absenteeism for individuals with migraine headache.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tkacz J, Brady BL, Meyer R, et al. (2015) An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease. Journal of Managed Care & Specialty Pharmacy. 21: 1064-76
Gunnarsson C, Chen J, Rizzo JA, et al. (2015) The Employee Absenteeism Costs of Rheumatoid Arthritis: Evidence From US National Survey Data. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 635-42
Siegel CA, Lofland JH, Naim A, et al. (2015) Novel Statistical Approach to Determine Inflammatory Bowel Disease: Patients' Perspectives on Shared Decision Making. The Patient
Siegel CA, Lofland JH, Naim A, et al. (2015) Gastroenterologists' Views of Shared Decision Making for Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 60: 2636-45
David G, Gunnarsson C, Lofland JH. (2015) Variations in care: a retrospective database analysis of healthcare utilization patterns for patients with inflammatory bowel disease. Journal of Medical Economics. 18: 137-44
Rizzo JA, Chen J, Gunnarsson CL, et al. (2015) Adjusting for comorbidities in cost of illness studies. Journal of Medical Economics. 18: 12-28
Tkacz J, Lofland JH, Vanderpoel J, et al. (2014) Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart review. American Health & Drug Benefits. 7: 87-93
Lofland JH, Mallow P, Rizzo J. (2013) Cost-per-remission analysis of infliximab compared to adalimumab among adults with moderate-to-severe ulcerative colitis. Journal of Medical Economics. 16: 461-7
Gunnarsson C, Chen J, Rizzo JA, et al. (2013) The employee absenteeism costs of inflammatory bowel disease: evidence from US National Survey Data. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 393-401
Gunnarsson C, Chen J, Rizzo JA, et al. (2012) Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey. Digestive Diseases and Sciences. 57: 3080-91
See more...